Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound‐activated interferon‐γ/interleukin‐10 axis

Mesenchymal stromal cell (MSC) therapies combined with renal pulsed focused ultrasound (pFUS) pretreatment increase MSC homing and improve cisplatin‐induced acute kidney injury (AKI) better than MSC alone. However, mechanisms underlying improved outcomes remain unknown. We hypothesize pFUS up‐regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Burks, Scott R., Nagle, Matthew E., Bresler, Michele N., Kim, Saejeong J., Star, Robert A., Frank, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237567/
https://www.ncbi.nlm.nih.gov/pubmed/30216653
http://dx.doi.org/10.1111/jcmm.13874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237567/
https://www.ncbi.nlm.nih.gov/pubmed/30216653
http://dx.doi.org/10.1111/jcmm.13874

Ejemplares similares